Prognosis Based Definition of Resectability in Pancreatic Cancer-Reference-Cited by-同舟云学术

Prognosis Based Definition of Resectability in Pancreatic Cancer

Published:2020-03-06 Issue:1 Volume:275 Page:175-181
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Oba Atsushi,Croce Chiara,Hosokawa Patrick,Meguid Cheryl,Torphy Robert J.,Al-Musawi Mohammed H.,Ahrendt Steven,Gleisner Ana,Schulick Richard D.,Del Chiaro Marco

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference34 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;Neoptolemos;N Engl J Med,2004

3. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators;Katz;Cancer,2012

4. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N Engl J Med,2018

5. Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer;Boggi;Surgery,2009

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: A retrospective study;Surgery;2024-09

2. The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer;Pancreatology;2024-09

3. Clinical impact of carbonic anhydrase 9 expression on neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma;Pancreatology;2024-09

4. Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model;International Journal of Nanomedicine;2024-09

5. Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma;Pancreas;2024-07